Exchange: NASDAQ·Updated 07:55 PM EDT
LXRX logo

LXRXLexicon Pharmaceuticals Inc

$2.32
$0.02
(0.85%)
Today
Closed $2.32
$0.07
(3.02%)
After Hours
EarningsAug 5
Mkt Cap$1.03B
Vol2.63M
News
all
press releases
Here's Why You Should Add LXRX Stock to Your Portfolio Now
Lexicon advances sotagliflozin into new indications while its obesity and pain programs progress, setting the stage for multiple pipeline milestones.
Zacks
News Placeholder
More News
News Placeholder
Lexicon Pharmaceuticals vs. Pfizer: Which Drugmaker Stock Is a Better Buy in 2026?
Key PointsLexicon Pharmaceuticals focuses on precision medicines for chronic conditions, bolstered by significant revenue growth from its core drug programs...
Nasdaq News: Markets
News Placeholder
Lexicon Pharmaceuticals (LXRX) Reports Break-Even Earnings for Q1
Lexicon (LXRX) delivered earnings and revenue surprises of +100.00% and +141.91%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
Lexicon Pharmaceuticals (NASDAQ:LXRX) Shares Cross Above 200-Day Moving Average - Here's What Happened
Lexicon Pharmaceuticals (NASDAQ:LXRX) Stock Price Passes Above 200-Day Moving Average - Here's What Happened...
MarketBeat
News Placeholder
Lexicon Pharmaceuticals (LXRX) to Release Earnings on Thursday
Lexicon Pharmaceuticals (NASDAQ:LXRX) will be releasing its Q1 2026 earnings before the market opens on Thursday, May 7. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-7-lexicon-pharmaceuticals-inc-stock...
MarketBeat
News Placeholder
Lexicon Pharmaceuticals (NASDAQ:LXRX) Reaches New 1-Year High - Here's Why
Lexicon Pharmaceuticals (NASDAQ:LXRX) Reaches New 52-Week High - What's Next...
MarketBeat
News Placeholder
Lexicon Pharmaceuticals (NASDAQ:LXRX) Reaches New 52-Week High - Should You Buy?
Lexicon Pharmaceuticals (NASDAQ:LXRX) Reaches New 52-Week High - Still a Buy...
MarketBeat
News Placeholder
Lexicon Pharmaceuticals (NASDAQ:LXRX) Trading 6.3% Higher - Still a Buy?
Lexicon Pharmaceuticals (NASDAQ:LXRX) Trading Up 6.3% - Here's What Happened...
MarketBeat
News Placeholder
Lexicon Pharmaceuticals (NASDAQ:LXRX) Stock Passes Above Two Hundred Day Moving Average - What's Next?
Lexicon Pharmaceuticals (NASDAQ:LXRX) Shares Pass Above 200 Day Moving Average - Here's What Happened...
MarketBeat
News Placeholder
Lexicon Pharmaceuticals (NASDAQ:LXRX) Trading 8.7% Higher - Time to Buy?
Lexicon Pharmaceuticals (NASDAQ:LXRX) Trading 8.7% Higher - Should You Buy...
MarketBeat
<
1
2
...
>

Advertisement|Remove ads.